Latest Headlines

1. Axplora Announces $60 Million High Potency API Manufacturing Facility Expansion In Italy 3/17/2026

   Axplora, a global leader in complex active pharmaceutical ingredient (API) manufacturing, today announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli. The latest phase includes construction of a new 4,500 m², three-storey R&D and laboratory hub, designed to accelerate development, expand execution capacity and deliver cost-efficient high-potency manufacturing at scale.

2. METTLER TOLEDO Launches New eGuide To Help Food Manufacturers Prevent Physical Contamination 3/17/2026
3. BD Announces $110 Million To Support U.S. Pharmaceutical Supply Chain For Biologic Drugs 3/16/2026

   BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery and supporting pharmaceutical reshoring in the U.S.

4. BD And Ypsomed Expand Partnership To Address Rapidly Growing Biologics Market 3/16/2026

   BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe.

5. ROSS PDDM-10 Planetary Dual Disperser Delivers Unmatched Pilot-Scale Processing Flexibility 3/10/2026

   The ROSS Model PDDM-10 Planetary Dual Disperser is a near-universal pilot scale mixer designed to deliver high shear and controlled planetary agitation under vacuum, enabling rapid solids dispersion and producing air-free, high-quality pastes, slurries, gels and putties. It can also handle powder blending, granulation and vacuum drying requirements. This mixer processes up to 12 gallons per batch with a full holding capacity of 15 gallons.

6. Emerson Streamlines Life Sciences Recipe Creation For Faster Time To Market 3/9/2026
7. Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California 3/6/2026

   Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product manufacturing in the United States.

8. Join Esco At INTERPHEX 2026 3/3/2026
9. Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team 3/3/2026

   Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.

10. Strategic Oral Solid Dose Facility Investment In Ireland Expands Novo Nordisk's Global Manufacturing Footprint 3/2/2026